Publications

Export 6 results:
Author Title [ Type(Asc)] Year
Filters: Author is MacQueen, Glenda  [Clear All Filters]
Journal Article
Wang JL, MacQueen G, Patten S, Manuel D, Lashewicz B, Schmitz N.  2019.  A randomized controlled trial to examine the impacts of disclosing personalized depression risk information on the outcomes of individuals who are at high risk of developing major depression: a research protocol.. BMC Psychiatry. 19(1):285.
Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N, Ardau R, Arias B, Backlund L, Banzato CEM et al..  2016.  Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study.. Lancet. 387(10023):1085-93.
Wang JLi, Patten S, Sareen J, Bolton J, Schmitz N, MacQueen G.  2014.  Development and validation of a prediction algorithm for use by health professionals in prediction of recurrence of major depression.. Depress Anxiety. 31(5):451-7.
Parikh SV, Hawke LD, Velyvis V, Zaretsky A, Beaulieu S, Patelis-Siotis I, MacQueen G, L Young T, Yatham LN, Cervantes P.  2015.  Combined treatment: impact of optimal psychotherapy and medication in bipolar disorder.. Bipolar Disord. 17(1):86-96.
Yatham LN, Kennedy SH, O'Donovan C, Parikh S, MacQueen G, McIntyre R, Sharma V, Silverstone P, Alda M, Baruch P et al..  2005.  Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.. Bipolar Disord. 7 Suppl 3:5-69.
Reinbold CS, Forstner AJ, Hecker J, Fullerton JM, Hoffmann P, Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K et al..  2018.  Analysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder.. Front Psychiatry. 9:207.